These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32883554)

  • 1. Evaluating the role of transient elastography post chronic hepatitis C treatment to predict hepatocellular carcinoma.
    Charette JH; Burak KW; Coffin CS; Congly SE; Lee SS; Israelson H; Williams S; Sadler M; Borman MA; Aspinall AI; Swain MG; Shaheen AA
    J Hepatol; 2020 Nov; 73(5):1287-1289. PubMed ID: 32883554
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: "Evaluating the role of transient elastography post chronic hepatitis C treatment to predict hepatocellular carcinoma".
    Genescà J
    J Hepatol; 2020 Nov; 73(5):1289-1290. PubMed ID: 32854982
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk assessment of hepatocellular carcinoma in chronic hepatitis C patients by transient elastography.
    Masuzaki R; Tateishi R; Yoshida H; Yoshida H; Sato S; Kato N; Kanai F; Sugioka Y; Ikeda H; Shiina S; Kawabe T; Omata M
    J Clin Gastroenterol; 2008 Aug; 42(7):839-43. PubMed ID: 18668703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy.
    Seo YS; Kim MN; Kim SU; Kim SG; Um SH; Han KH; Kim YS
    Medicine (Baltimore); 2016 Mar; 95(12):e2985. PubMed ID: 27015173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histological findings in the liver in patients with chronic hepatitis C].
    Takase K; Shiraki K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):434-8. PubMed ID: 15359838
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.
    Kim JH; Kim MN; Han KH; Kim SU
    Liver Int; 2015 Apr; 35(4):1103-15. PubMed ID: 24976523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hepatitis C virus-related cirrhosis].
    Bronowicki JP
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B220-4. PubMed ID: 12180292
    [No Abstract]   [Full Text] [Related]  

  • 8. Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography.
    Pérez-Latorre L; Sánchez-Conde M; Rincón D; Miralles P; Aldámiz-Echevarría T; Carrero A; Tejerina F; Díez C; Bellón JM; Bañares R; Berenguer J
    Clin Infect Dis; 2014 Mar; 58(5):713-8. PubMed ID: 24265358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C.
    Na SK; Song BC
    Clin Mol Hepatol; 2019 Sep; 25(3):234-244. PubMed ID: 30661334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of interferon therapy on histology and development of hepatocellular carcinoma in hepatitis C.
    Omata M; Shiratori Y
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E134-40. PubMed ID: 10921397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs.
    Søholm J; Hansen JF; Mössner B; Røge BT; Lauersen A; Hansen JB; Weis N; Barfod TS; Lunding S; Øvrehus A; Mohey R; Thielsen P; Christensen PB
    PLoS One; 2020; 15(12):e0243725. PubMed ID: 33301499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early decrease of liver stiffness after initiation of antiviral therapy in patients with chronic hepatitis C.
    Moser S; Gutic E; Schleicher M; Gschwantler M
    Dig Liver Dis; 2016 Aug; 48(8):970-1. PubMed ID: 27260330
    [No Abstract]   [Full Text] [Related]  

  • 13. Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study.
    Romano A; Angeli P; Piovesan S; Noventa F; Anastassopoulos G; Chemello L; Cavalletto L; Gambato M; Russo FP; Burra P; Vincenzi V; Scotton PG; Panese S; Tempesta D; Bertin T; Carrara M; Carlotto A; Capra F; Carolo G; Scroccaro G; Alberti A
    J Hepatol; 2018 Aug; 69(2):345-352. PubMed ID: 29551707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver stiffness measurements in chronic hepatitis C: Treatment evaluation and risk assessment.
    Nakagomi R; Tateishi R; Masuzaki R; Soroida Y; Iwai T; Kondo M; Fujiwara N; Sato M; Minami T; Uchino K; Enooku K; Nakagawa H; Asaoka Y; Kondo Y; Tanaka Y; Otsuka M; Kato N; Moriya K; Ikeda H; Koike K
    J Gastroenterol Hepatol; 2019 May; 34(5):921-928. PubMed ID: 30393960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy.
    Wang JH; Yen YH; Yao CC; Hung CH; Chen CH; Hu TH; Lee CM; Lu SN
    Liver Int; 2016 Dec; 36(12):1793-1799. PubMed ID: 27254286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic change of LSM-HCC score and enhanced liver fibrosis score to predict hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral treatment: abridged secondary publication.
    Wong GLH; Wong VWS
    Hong Kong Med J; 2022 Feb; 28 Suppl 1(1):11-13. PubMed ID: 35260508
    [No Abstract]   [Full Text] [Related]  

  • 17. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.
    Jeon MY; Lee HW; Kim SU; Heo JY; Han S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
    Hepatol Int; 2017 May; 11(3):268-276. PubMed ID: 28224351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease.
    Park MS; Han KH; Kim SU
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):501-11. PubMed ID: 24939348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Hepatocellular Carcinoma After Sustained Virological Responses Using Magnetic Resonance Elastography.
    Higuchi M; Tamaki N; Kurosaki M; Watakabe K; Osawa L; Wang W; Okada M; Shimizu T; Takaura K; Takada H; Kaneko S; Yasui Y; Tsuchiya K; Nakanishi H; Itakura J; Takahashi Y; Izumi N
    Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2616-2618. PubMed ID: 30502507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.
    Posthouwer D; Mauser-Bunschoten EP; Fischer K; VAN Erpecum KJ; DE Knegt RJ
    J Thromb Haemost; 2007 Jan; 5(1):25-30. PubMed ID: 17239163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.